-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 PCsl8wpOuSgZvt0eGaMsxiYJXKHw/2/dLAfij1OVM9fTJGXp9LgLqCTiwO+rP50s
 WpVyyxnlXfZ43F/Wu+oO5A==

<SEC-DOCUMENT>0000950123-10-091080.txt : 20101004
<SEC-HEADER>0000950123-10-091080.hdr.sgml : 20101004
<ACCEPTANCE-DATETIME>20101004132631
ACCESSION NUMBER:		0000950123-10-091080
CONFORMED SUBMISSION TYPE:	SC 14D9/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20101004
DATE AS OF CHANGE:		20101004

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BlueLinx Holdings Inc.
		CENTRAL INDEX KEY:			0001301787
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-LUMBER, PLYWOOD, MILLWORK & WOOD PANELS [5031]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0101

	FILING VALUES:
		FORM TYPE:		SC 14D9/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-80230
		FILM NUMBER:		101104877

	BUSINESS ADDRESS:	
		STREET 1:		4300 WILDWOOD PARKWAY
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30339
		BUSINESS PHONE:		770-953-7000

	MAIL ADDRESS:	
		STREET 1:		4300 WILDWOOD PARKWAY
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30339

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BlueLinx Holdings Inc.
		CENTRAL INDEX KEY:			0001301787
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-LUMBER, PLYWOOD, MILLWORK & WOOD PANELS [5031]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0101

	FILING VALUES:
		FORM TYPE:		SC 14D9/A

	BUSINESS ADDRESS:	
		STREET 1:		4300 WILDWOOD PARKWAY
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30339
		BUSINESS PHONE:		770-953-7000

	MAIL ADDRESS:	
		STREET 1:		4300 WILDWOOD PARKWAY
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30339
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 14D9/A
<SEQUENCE>1
<FILENAME>g24793sc14d9za.htm
<DESCRIPTION>SC 14D9/A
<TEXT>
<HTML>
<HEAD>
<TITLE>sc14d9za</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>


<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>SCHEDULE 14D-9</b><BR></div>

<DIV align="center" style="font-size: 10pt; margin-top: 0pt"><b>(Rule&nbsp;14d-101)<BR>
(Amendment No.&nbsp;2)</B>
</DIV>

<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>Solicitation/Recommendation Statement<BR>
Under Section&nbsp;14(d)(4) of the Securities Exchange Act of 1934</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>BLUELINX HOLDINGS INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><I>(Name of Subject Company)</I></DIV>


<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>BLUELINX HOLDINGS INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><I>(Name of Person Filing Statement)</I></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Common stock, par value $0.01 per share</B><BR>
<I>(Title of Class of Securities)</I></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>09624H109</B><BR>
<I>(CUSIP Number of Class of Securities)</I></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Dean A. Adelman<BR>
Chief Administrative Officer<BR>
4300 Wildwood Parkway<BR>
Atlanta, Georgia 30339<BR>
(770)&nbsp;953-7000</B><BR>
<I>(Name, address and telephone number of person authorized to receive<BR>
notices and communications on behalf of the persons filing statement)</I></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B><I>With copies to:</I></B></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Sara Epstein, Esq. <BR>
BlueLinx Corporation <BR>
4300 Wildwood Parkway <BR>
Atlanta, Georgia 30339<BR>
(770)&nbsp;953-7000</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Mark L. Hanson, Esq.<BR>
Jones Day<BR>
1420 Peachtree St., N.E.<BR>
Atlanta, GA 30309<BR>
(404)&nbsp;521-3939</B></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT style="font-family: Wingdings">&#111;</FONT> Check the box if the filing relates solely to preliminary communications made before the
commencement of a tender offer.
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>













<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD></TD><TD colspan="8"><A HREF="#000">Item&nbsp;2. Identity and Background of Filing Person.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;4. The Solicitation or Recommendation</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#002">Item&nbsp;8. Additional Information</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#003">Item&nbsp;9. Exhibits</A></TD></TR>
<TR><TD colspan="9"><A HREF="#004">SIGNATURE</A></TD></TR>
<TR><TD colspan="9"><A HREF="g24793exv99wew15.htm">EX-99.E.15</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Purpose of the Amendment</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment No.&nbsp;2 (this &#147;<B>Amendment</B>&#148;) amends and supplements the Solicitation/Recommendation
Statement on Schedule&nbsp;14D-9 (together with the exhibits and annexes thereto and as amended and
supplemented from time to time, the &#147;<B>Schedule&nbsp;14D-9</B>&#148;), originally filed with the Securities and
Exchange Commission (the &#147;<B>Commission</B>&#148;) on August&nbsp;13, 2010 by BlueLinx Holdings Inc., a Delaware
corporation (the &#147;<B>Company</B>&#148; or &#147;<B>BlueLinx</B>&#148;) and subsequently amended and restated on September&nbsp;27,
2010, relating to the tender offer by Cerberus ABP Investor LLC, a Delaware limited liability
company (&#147;<B>CAI</B>&#148;), and a wholly-owned subsidiary of Cerberus Capital Management, L.P. (&#147;<B>Cerberus
Capital</B>&#148;), pursuant to which CAI has offered to purchase all outstanding shares of common stock,
par value $0.01 per share of the Company (the &#147;<B>Shares</B>&#148;) not otherwise owned by CAI for $4.00 net
per Share in cash, without interest and less any applicable withholding taxes (the &#147;<B>Offer Price</B>&#148;),
upon the terms and subject to the conditions set forth in the Offer to Purchase, dated August&nbsp;2,
2010, as supplemented by the Second Supplement to Offer to Purchase dated September&nbsp;22, 2010, and
the related Letter of Transmittal (which, together with any amendments or supplements thereto,
collectively, constitute the &#147;<B>Offer</B>&#148;). The Offer is described in a Tender Offer Statement on
Schedule&nbsp;TO, filed by CAI and Cerberus Capital with the Commission on August&nbsp;2, 2010 (as amended
and/or supplemented from time to time, and together with the Exhibits thereto, the &#147;<B>Schedule&nbsp;TO</B>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All information in the Schedule&nbsp;14D-9 is incorporated into this Amendment by reference, except
that such information is hereby amended to the extent specifically provided herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment is being filed to reflect certain updates as reflected below.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All references to &#147;(other than CAI and Cerberus Capital)&#148; in the Schedule&nbsp;14D-9 are deleted in
their entirety and replaced with &#147;(other than CAI, Cerberus Capital, the Company&#146;s directors and
executive officers and other affiliates).&#148;
</DIV>

<!-- link2 "Item&nbsp;2. Identity and Background of Filing Person." -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;2. Identity and Background of Filing Person.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The
last sentence of the first paragraph under the subheading
&#147;&#151;Tender Offer&#148; is deleted and replaced in its
entirety with the following:</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;According
to the Schedule&nbsp;TO, the Offer is scheduled to remain open from
August&nbsp;2, 2010 until 12:00&nbsp;midnight, New York City time on
October&nbsp;18, 2010 (the &#147;<B>Offer Period</B>&#148;), unless
extended by CAI.
</DIV>

<!-- link2 "Item&nbsp;4. The Solicitation or Recommendation" -->
<DIV align="left"><A NAME="001"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;4. The Solicitation or Recommendation.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Background of the Offer.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The following sentences are inserted at the end of the 20</I><SUP style="FONT-size: 85%; vertical-align: text-top"><I>th</I></SUP><I> paragraph of this
section:</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In light of CAI&#146;s statement in its Letter to the Board, dated July&nbsp;21, 2010, that in its
capacity as a stockholder CAI was only interested in acquiring Shares it did not already own, and
that it neither had any current interest in selling its Shares nor in voting in favor of any
alternative sale, merger or other such transaction, the Special Committee did not believe there was
any viable alternative transaction involving the sale of the Company as a whole that could be
explored or pursued without CAI&#146;s support. Consequently, the Special Committee determined that
exploring the potential acquisition of the entire minority interest by a third party was the only
alternative transaction that could reasonably be explored at this time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The 33</I><SUP style="FONT-size: 85%; vertical-align: text-top"><I>rd</I></SUP><I> paragraph of this section is deleted and replaced in its entirety with
the following paragraph:</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On August&nbsp;11 and 12, 2010, the Special Committee held telephonic meetings to discuss the
Schedule&nbsp;14D-9 and the Offer. At the meeting on August&nbsp;12, the representatives of Citadel
Securities informed the Special Committee that the remaining third party that had expressed an
interest in exploring a potential acquisition of the Company&#146;s Shares not currently owned by CAI no
longer was interested in pursuing such an acquisition. In light of CAI&#146;s stated position that it
had no current interest in selling its Shares, the Special Committee determined that there were no
other currently available alternative transactions, and that it should continue to evaluate the
Offer and engage in discussions with CAI. At the conclusion of the meetings, the Special Committee
determined that it was unable to take a position with respect to the Offer at that time and
authorized the Company to finalize and file a Schedule&nbsp;14D-9. The Special Committee determined to
request that stockholders of the Company take no action and not tender their Shares with respect to
the Offer at that time, and instead defer making a determination of whether to accept or reject the
Offer until the Special Committee has advised stockholders of its position or recommendation, if
any, with respect to the Offer.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The last two paragraphs of this section are deleted and replaced in their entirety with
the following paragraphs</I>:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following the discussion, the Special Committee unanimously determined, by all members
participating in the deliberations, that the Offer is fair, from a financial point of view, to the
Company&#146;s stockholders (other than CAI, Cerberus Capital, the Company&#146;s directors and executive
officers and other affiliates) and to recommend on behalf of the Company and the Board, that such
stockholders accept the Offer and tender their Shares pursuant to the Offer. The Company, through
the Special Committee as authorized by the Board, also determined that the Offer is fair, from a
financial point of view, to the Company&#146;s stockholders (other than CAI, Cerberus Capital, the
Company&#146;s directors and executive officers and other affiliates).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective on September&nbsp;27, 2010, after the Special Committee informed CAI and Cerberus Capital
that it, on behalf of the Company, had determined to issue a favorable recommendation with respect
to the amended Offer, the Company, CAI and Cerberus Capital entered into the Stockholder Agreement
in the form that had been agreed upon between the parties on September&nbsp;22, 2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On September&nbsp;27, 2010, the Company issued a press release announcing that the Special
Committee, on behalf of the Company, was recommending that stockholders accept the Offer at the increased Offer Price of $4.00
per Share and tender their Shares pursuant to the Offer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On September&nbsp;28, 2010, the Special Committee received a letter from Stadium Capital Management
LLC, (&#147;<B>Stadium Capital</B>&#148;), which holds approximately 5% of the outstanding Shares. In the letter,
which Stadium Capital also filed with the Commission, Stadium Capital expressed its continuing
opposition to the Offer and to the increased Offer Price, and requested that the Special Committee
reconsider its recommendation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On October&nbsp;1, 2010, the Special Committee held a telephonic
meeting, which included representatives of Citadel Securities and Jones Day, to review the
communication from Stadium Capital. Following a discussion of the points raised by Stadium Capital
in its letter, the Special Committee determined to stand by its recommendation of the Offer, and
the reasons therefor, all as previously announced on September&nbsp;27, 2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
October&nbsp;4, 2010, prior to the opening of trading on the NYSE,
CAI announced a further extension of the expiration time of the Offer
to midnight, New York City time, on Monday, October&nbsp;18, 2010. In
the announcement, CAI stated that the purpose of the extension was to
allow stockholders of the Company additional time to review the terms
of the amended Offer and the Company&#146;s amended
Solicitation/Recommendation Statement on Schedule&nbsp;14D-9, which
was filed on September&nbsp;27, 2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Reasons for the Special Committee&#146;s Position.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The first paragraph of this section is deleted and replaced in its entirety with the following
paragraph:</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In reaching its recommendation that the Offer Price is fair, from a financial point of view,
to the Company&#146;s stockholders (other than CAI, Cerberus Capital, the Company&#146;s directors and
executive officers and other affiliates), the Special Committee, on its behalf and on behalf of the
Company and the Board, considered a number of factors, including the following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The following paragraph is inserted immediately following the second paragraph of this
section</I>:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Trading Market and Liquidity</I>. The Special Committee considered the historical market prices
and trading activity of the Shares on the NYSE, including the generally low trading volume and
resulting lack of liquidity for stockholders, and the risk of further erosion of the market price
for the Shares as a result of current conditions in the financial and housing markets generally.
The Special Committee also considered the fundamental dislocations that have occurred in the
financial and housing markets over the past few years, which has had a number of consequences,
including creating a larger disparity between current trading prices of equity securities and
historical trading prices, and which, in the Special Committee&#146;s view, make financial metrics,
including historical trading prices, from prior periods less relevant
to a current analysis of the value of the Shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The following paragraphs are inserted immediately preceding the last paragraph of this
section:</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In reaching its conclusion as to fairness, the Special Committee concluded, consistent with
the view of its financial advisor, that a valuation of the Company as a going concern was the most
appropriate valuation approach to apply. The Special Committee&#146;s conclusion was based primarily on
the fact that CAI had explicitly stated that it had no interest in selling its Shares nor in voting
in favor of any alternative sale, merger or other such transaction,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 2 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">together with the view that a going concern valuation approach was most appropriate in light
of the nature of the Company&#146;s business and its ongoing viability as a going concern, all as
described in more detail in&#147;&#151; Opinion of the Special Committee&#146;s Financial Advisor, Citadel
Securities LLC.&#148; As such, the Special Committee did not consider the liquidation value of the
Company&#146;s assets. Therefore, no appraisal of liquidation value was sought for purposes of valuing
the Company&#146;s Shares, and the Special Committee believed that the liquidation value of the Company
was not a meaningful indicator of value for a distribution business such as the Company&#146;s and was
therefore not relevant to a determination as to whether the Offer is fair to the unaffiliated
stockholders. Further, the Special Committee did not consider net book value as a factor because it
believed that net book value is an accounting concept that is not a material indicator of the value
of the Company as a going concern, particularly for companies in the building products distribution
sector.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Opinion of the Special Committee&#146;s Financial Advisor, Citadel Securities LLC.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The second paragraph of this section under the subheading &#147; &#151;Miscellaneous&#148; is replaced in
its entirety with the following paragraph:</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to an engagement letter dated July&nbsp;27, 2010, the Company is obligated to pay Citadel
Securities a fee in an amount of $1,500,000 in connection with the services rendered to the Special
Committee. In addition, the Company has also agreed to reimburse Citadel Securities for its
reasonable expenses, including attorneys&#146; fees and disbursements, and to indemnify Citadel
Securities and related persons against certain liabilities relating to or arising out of its
engagement.
</DIV>


<!-- link2 "Item&nbsp;8. Additional Information" -->
<DIV align="left"><A NAME="002"></A></DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8. Additional Information.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Litigation.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The following paragraph is inserted after the last paragraph of this subsection:</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On September&nbsp;30, 2010 an individual stockholder of the Company filed a
complaint in the U.S. District Court for the Northern District of Georgia commencing a putative
class action lawsuit against CAI, Cerberus Capital, the Company and each of the individual members
of the Board. This complaint, styled as <I>Ajay Kajaria v. Howard S. Cohen, et al</I>. (Case No.
1:10-CV-03141-JOF), seeks, among other remedies, to preliminarily and permanently enjoin the Offer
and Merger, to rescind the proposed transaction, to the extent already implemented, and the award
of damages and attorneys&#146; fees. In general, the complaint alleges, among other things, that the
members of the Board breached their fiduciary duty and CAI and Cerberus Capital aided and abetted
such breach of fiduciary duty by, among other things, allegedly failing to disclose material facts
regarding the Offer and the Merger. The Company believes this case has no merit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The following is inserted at the end of this section:</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Financial Information</I></B>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth summary historical financial data for the Company as of and for
each of the fiscal year ended January&nbsp;2, 2010 and the fiscal year ended January&nbsp;3, 2009 and the six
months ended July&nbsp;3, 2010. The selected financial information set forth below is derived from, and
should be read in conjunction with, the audited financial statements and other financial
information contained in the Company&#146;s Annual Report on Form 10-K filed with the Commission on
March&nbsp;2, 2010 for the year ended January&nbsp;2, 2010 (the &#147;<B>2009 10-K</B>&#148;) and the unaudited financial
statements and other financial information contained in the Company&#146;s Quarterly Report on Form 10-Q
filed with the Commission on August&nbsp;6, 2010 for the quarter ended July&nbsp;3, 2010 (the &#147;<B>Second Quarter
2010 10-Q</B>&#148;), including the notes thereto, which contain more comprehensive financial information
(including management&#146;s discussion and analysis of financial condition and results of operation).
The following summary is qualified in its entirety by reference to the information contained in the
2009 10-K and the Second Quarter 2010 10-Q and the financial statements included as Item&nbsp;8 in the
2009 10-K and Item&nbsp;1 of the Second Quarter 2010 10-Q are incorporated by reference herein. Copies
of reports and documents filed by the Company with the Commission can be inspected and copied at
the Commission&#146;s Public Reference Room at 100 F Street, N.E., Washington, D.C.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->- 3 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">20549. Please call 1-800-SEC-0330 for further information on the operation of the Public
Reference Room. The Commission also maintains a website on the Internet (http://www.sec.gov) that
contains such reports and documents.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="64%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Six Months</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Ended</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Year Ended</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Year Ended</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>July 3, 2010</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>January 2,</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>January 3,</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>(unaudited)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>2010</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>2009</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="10"><B>(In thousands, except per share data)</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Statement of Operations Data:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net sales</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">971,831</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">1,646,108</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2,779,699</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cost of sales</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">855,434</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,452,947</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,464,766</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Gross profit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">116,397</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">193,161</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">314,933</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net loss</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(18,146</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(61,463</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(31,703</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Comparative per Share Data:</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Basic net loss per share applicable to common stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(0.59</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(1.98</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(1.02</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diluted net loss per share applicable to common stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(0.59</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(1.98</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(1.02</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Dividends
declared per share of common stock(1)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Book value
per share(2)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.05</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.58</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Balance Sheet Data (at end of period):</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash and cash equivalents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">18,821</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">29,457</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">150,353</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Working capital</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">265,524</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">247,722</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">320,527</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">644,047</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">546,846</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">729,178</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total debt(3)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">410,356</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">341,669</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">444,870</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Shareholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">34,368</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">50,820</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">102,852</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Ratio of
Earnings to Fixed Charges(4)</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">(0.22)x</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">(0.31)x</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">(0.12)x</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>The last dividend paid by the Company was on
December&nbsp;28, 2007 for the third quarter ended September&nbsp;29, 2007.
</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Book value per share is calculated by dividing total stockholders&#146; equity by the number of
shares of common stock outstanding.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Total debt represents long-term debt, including current maturities.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(4)</TD>
    <TD>&nbsp;</TD>
    <TD>Earnings for the six months ended July&nbsp;3, 2010 and the years ended January&nbsp;2, 2010 and
January&nbsp;3, 2009 were inadequate to cover fixed charges by $18.1&nbsp;million, $56.9&nbsp;million and
$48.1&nbsp;million, respectively.</TD>
</TR>


</TABLE>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Prior Stock Purchases.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On December&nbsp;22, 2008, the Board approved a stock repurchase program authorizing the Company to
repurchase up to $10,000,000 of outstanding common stock. Below is a listing of the shares
repurchased since 2009 (by quarter) and information relating to the repurchase price of those
shares. No shares were repurchased by the Company in 2008.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="28%">&nbsp;</TD>
    <TD width="41%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Average</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Total Number of</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Purchase</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Period</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares Purchased</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Range of Prices</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Price</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="13" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px"><B>2010</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">First Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">199,328</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD nowrap align="right">2.68-$3.03</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2.93</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Second Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center"><DIV style="margin-left:15px; text-indent:-15px"><B>2009</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">First Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">363,018</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD nowrap align="right">1.37-$2.90</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2.18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Second Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">273,287</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD nowrap align="right">2.78-$3.27</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">3.05</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Third Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">75,547</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD nowrap align="right">3.10-$3.27</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">3.16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Fourth Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">60,196</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD nowrap align="right">2.69-$3.03</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2.90</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 4 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Trading Market and Price</I></B><I>.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Shares currently are traded on the NYSE under the symbol &#147;BXC.&#148; The table below sets forth
the quarterly range of high and low sales prices for Shares as reported on the NYSE with respect to
the periods occurring in fiscal year 2008 and 2009 for each quarter during 2010.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>High</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Low</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Fiscal Year 2010</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Third Quarter (through September&nbsp;30, 2010)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">4.10</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2.24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Second Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.32</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">First Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.11</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Fiscal Year 2009 (ended January&nbsp;2, 2010)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Fourth Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">4.12</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2.60</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Third Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.93</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.96</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Second Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4.60</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">First Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.30</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1.20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Fiscal Year 2008 (ended January&nbsp;3, 2009)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Fourth Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">5.60</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">1.02</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Third Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7.54</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.91</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Second Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6.00</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3.57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">First Quarter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5.97</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2.96</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<!-- link2 "Item&nbsp;9. Exhibits" -->
<DIV align="left"><A NAME="003"></A></DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9. Exhibits.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Item&nbsp;9 is hereby amended to add the following exhibit</I>:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">(e)(15)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Complaint entitled <I>Ajay Kajaria v. Howard S. Cohen, et al.</I>
filed on September&nbsp;30, 2010 in the United States District
Court for the Northern District of Georgia.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->- 5 -<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "SIGNATURE" -->
<DIV align="left"><A NAME="004"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After due inquiry and to the best of my knowledge and belief, I certify that the information
set forth in this Statement is true, complete and correct.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>BLUELINX HOLDINGS INC.</B>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">                                                  /s/ H. Douglas Goforth
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">H. Douglas Goforth&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Chief Financial Officer and Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dated: October&nbsp;4, 2010
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->- 6 -<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.E.15
<SEQUENCE>2
<FILENAME>g24793exv99wew15.htm
<DESCRIPTION>EX-99.E.15
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99wew15</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit (e) (15)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>UNITED STATES DISTRICT COURT<BR>
NORTHERN DISTRICT OF GEORGIA</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left">AJAY KAJARIA, Individually and On<BR>
Behalf of All Others Similarly Situated,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Case No. <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Plaintiff,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">v.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" valign="top" align="left" rowspan="2">HOWARD S. COHEN, RICHARD S. GRANT,
GEORGE R. JUDD, CHARLES H.
McELREA, RICHARD B. MARCHESE,
STEVEN F. MAYER, ALAN H. SCHUMACHER, MARK A. SUWYN,
ROBERT G.WARDEN, M.RICHARD
WARNER, BLUELINX HOLDINGS INC.,
CERBERUS ABP INVESTOR LLC and
CERBERUS CAPITAL MANAGEMENT,
L.P.,</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><U><B>CLASS ACTION COMPLAINT</B></U><BR></TD>
</TR>
<TR valign="bottom">

    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>JURY TRIAL DEMANDED</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Defendants.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff, Ajay Kajaria (&#147;Plaintiff&#146;) by his attorneys, for his complaint against defendants,
alleges upon personal knowledge as to himself, and upon information and belief as to all other
allegations herein, as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><u><B>NATURE OF THE ACTION</B></u>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;This is a shareholder class action brought by Plaintiff on behalf of himself and
all other similarly situated shareholders of BlueLinx Holdings Inc.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(&#147;BlueLinx&#148; or the &#147;Company&#148;) against the Company&#146;s Board of Directors (the &#147;Individual
Defendants&#148;), Cerberus ABP Investor LLC, (&#147;CAI&#148;), and Cerberus Capital Management, L.P.
(&#147;Cerberus&#148;), which controls CAI, in connection with the proposed acquisition of BlueLinx (the
&#147;Proposed Transaction&#148;) pursuant to a tender offer (the &#147;Tender Offer&#148;) by CAI which is currently
scheduled to expire at midnight on October&nbsp;8, 2010. The Proposed Transaction is unfair both with
respect to price and process and is designed to benefit CAI and Cerberus to the detriment of
Plaintiff and the Class (defined herein).
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>JURISDICTION AND VENUE</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;This
Court has jurisdiction over all claims asserted herein pursuant to 28 U.S.C &#167;133l in that Plaintiff&#146;s claims arise in part under the Constitution and laws of the United
States, including the Securities Exchange Act &#091;15 U.S.C. &#167;78aa&#093; and 28 U.S.C. &#167;1331. This Court also
has supplemental jurisdiction pursuant to 28 U.S.C. &#167;1367(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;This Court also has jurisdiction over this action pursuant to 28 US.C.&#167;&#167;
1332(a), (c), and (d)&nbsp;as Plaintiff and the defendants are citizens of and domiciled in different
states and the amount in controversy exceeds $75,000, exclusive of interests and costs. Given that
the Proposed Transaction is valued at
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">$49.56&nbsp;million, the injunctive relief sought herein will exceed a sum or value of $75,000. This
action is not a collusive one to confer jurisdiction on this Court.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;Venue is proper in this Court pursuant to 28 U.S.C. &#167;139l because one or more
of the defendants, including BlueLinx either resides in or maintains executive offices in this
District, and a substantial portion of the transactions and wrongs that are the subject of this
complaint, occurred in substantial part in this District. Finally, the defendants have received
substantial compensation in this District by doing business here and engaging in numerous
activities that had an effect in this District.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>THE PARTIES</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;Plaintiff is and was, at all times relevant hereto, a holder of BlueLinx common
stock. Plaintiff is a citizen of Rhode Island.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;BlueLinx is a Delaware corporation headquartered at 4300 Wildwood Parkway,
Atlanta, Georgia 30339. The Company&#146;s primary business is the distribution of approximately 10,000
building products to 11,500 customers through its network of 70 warehouses and third-party operated
warehouses. BlueLinx common stock is traded on the New York Stock Exchange under the symbol &#147;BXC.&#148;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;Defendant Howard S. Cohen (&#147;Cohen&#148;) is, and has been at all times relevant
hereto, a member of the Company&#146;s Board of Directors (&#147;Board&#148;). Defendant Cohen is Chairman of the
Board. Prior to joining BlueLinx as an executive officer, Cohen was a senior advisor of Cerberus
and currently serves on the boards of directors of two other Cerberus portfolio companies.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;Defendant Richard S. Grant (&#147;Grant&#148;) is, and has been at all times relevant
hereto, a member of the Company&#146;s Board.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;Defendant George R. Judd (&#147;Judd&#148;) is, and has been at all times relevant
hereto, a member of the Company&#146;s Board. Judd has served as the Company&#146;s Chief Executive officer
since October&nbsp;2008, and as the Company&#146;s President and Chief Operating Officer since May&nbsp;2004.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;Defendant Charles H. McElrea (&#147;McElrea&#148;) is, and has been at all times
relevant hereto, a member of the Company&#146;s Board.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;Defendant Richard B. Marchese (&#147;Marchese&#148;) is, and has been at all times
relevant hereto, a member of the Company&#146;s Board.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.&nbsp;Defendant Steven F. Mayer (&#147;Mayer&#148;) is, and has been at all times relevant
hereto, a member of the Company&#146;s Board. Defendant Mayer is a Managing Director of Cerberus.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.&nbsp;Defendant Alan H. Schumacher (&#147;Schumacher&#148;) is, and has been at all times
relevant hereto, a member of the Company&#146;s Board. Schumacher currently serves on the boards of
directors of other companies affiliated with Cerberus. Schumacher was previously appointed to the
Board&#146;s Special Committee (defined herein) until he recused himself.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.&nbsp;Defendant Mark A. Suwyn (&#147;Suwyn&#148;) is, and has been at all times
relevant hereto, a member of the Company&#146;s Board. Suwyn has previously served as a senior member of
the Cerberus operations team and as an advisor to Cerberus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.&nbsp;Defendant Robert G. Warden (&#147;Warden&#148;) is, and has been at all times relevant
hereto, a member of the Company&#146;s Board. Defendant Warden is a Managing Director of Cerberus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.&nbsp;Defendant M. Richard Warner (&#147;Warner&#148;) is, and has been at all times
relevant hereto, a member of the Company&#146;s Board. Defendant Warner is a consultant for Cerberus and
also serves on the board of directors of a Cerberus portfolio company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.&nbsp;The Defendants listed in paragraphs 7 through 16 are collectively
referred to as the &#147;Individual Defendants.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18.&nbsp;Defendant CAI, a Delaware limited liability company controlled by Cerberus,
maintains its principal executive office in New York, New York and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">currently owns 18.1&nbsp;million shares or 55.39&nbsp;percent of BlueLinx&#146;s outstanding
common stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19.&nbsp;Defendant Cerberus, a Delaware limited partnership headquartered in New York,
New York, is a private investment firm with approximately $23&nbsp;billion under management. Cerberus
controls CAI, which in turns owns 55.39&nbsp;percent of BlueLinx&#146;s outstanding common stock. Individual
Defendants Cohen, Mayer, Schumacher, Suwyn, Warden, and Warner all serve on BlueLinx&#146;s Board and
are affiliated with Cerberus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20.&nbsp;Defendants BlueLinx, CAI, and Cerberus are named herein as aiders and abettors
to the breaches of fiduciary duty described herein.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>THE INDIVIDUAL DEFENDANTS&#146; FIDUCIARY DUTIES</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21.&nbsp;By reason of the above Individual Defendants&#146; positions with the Company as
directors and/or officers, said individuals are in a fiduciary relationship with Plaintiff and the
other stockholders of BlueLinx who are being and will be harmed by the defendants&#146; actions
described herein (the &#147;Class&#148;) and owe Plaintiff and the other members of the Class a duty of
highest good faith, fair dealing, loyalty and full and adequate disclosure.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22.&nbsp;Each of the Individual Defendants is required to act in good faith, in the
best interests of the Company&#146;s shareholders and with such care, including
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">reasonable inquiry, as would be expected of an ordinarily prudent person. In a situation where the
directors of a publicly traded company undertake a transaction that may result in a change in
corporate control, the applicable state law requires the directors to take all steps reasonably
required to maximize the value shareholders will receive rather than use a change of control to
benefit themselves. To diligently comply with this duty, the directors of a corporation may not
take any action that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;adversely affects the value provided to the corporation&#146;s shareholders;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;contractually prohibits them from complying with or carrying out their fiduciary
duties;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;discourages or inhibits alternative offers to purchase control of the corporation or its
assets; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;will otherwise adversely affect their duty to search and secure the best value
reasonably available under the circumstances for the corporation&#146;s shareholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23.&nbsp;In accordance with their duties of loyalty and good faith, the Individual
Defendants, as directors and/or officers of BlueLinx, are obligated under applicable law to refrain
from:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;participating in any transaction where the directors&#146; or officers&#146; loyalties are divided;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) participating in any transaction where the directors or officers receive, or are entitled to
receive, a personal financial benefit not equally shared by the public shareholders of the
corporation; and/or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;unjustly enriching themselves at the expense or to the detriment of the public
shareholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24.&nbsp;The Individual Defendants are also obliged to honor their duty of candor to
BlueLinx&#146;s shareholders by, <I>inter alia, </I>providing all material information to the
shareholders regarding a scenario in which they are asked to tender their shares. This duty of
candor ensures that shareholders have all information that will enable them to make informed,
rational and intelligent decisions about whether to relinquish their shares in exchange for the
consideration offered.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25.&nbsp;Plaintiff alleges herein that the Individual Defendants, separately and
together, in connection with the Proposed Transaction, are knowingly or recklessly violating their
fiduciary duties, including their duties of loyalty, good faith, and independence owed to Plaintiff
and other shareholders of BlueLinx. The Individual Defendants stand on both sides of the
transaction, are engaging in self dealing, are obtaining for themselves personal benefits,
including personal
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">financial benefits, not shared equally by Plaintiff or the Class. As a result of the
Individual Defendants&#146; self dealing and divided loyalties, neither Plaintiff nor the Class will
receive adequate or fair value for their BlueLinx common stock in the Proposed Transaction.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26.&nbsp;Because the Individual Defendants are knowingly or recklessly breaching their
duties of loyalty, good faith, and independence in connection with the Proposed Transaction, and
because the Proposed Transaction involves a Tender Offer by a controlling shareholder, the burden
of proving the entire fairness of the Proposed Transaction, including all aspects of its
negotiation, structure, price, and terms is placed on the defendants as a matter of law.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>CLASS ACTION ALLEGATIONS</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27.&nbsp;Plaintiff brings this action pursuant to Rule&nbsp;23 on behalf of himself and all
other shareholders of the Company (except the defendants herein and any persons, firm, trust,
corporation, or other entity related to or affiliated with them and their successors in interest),
who are, or will be, threatened with injury arising from defendants&#146; actions, as more fully
described herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28.&nbsp;This action is properly maintainable as a class action for the following
reasons: The Class is so numerous that joinder of all members is impracticable. As
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">of September&nbsp;24, 2010, there were over 32.69&nbsp;million shares of BlueLinx common stock issued and
outstanding, likely owned by thousands of shareholders.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29.&nbsp;Plaintiff is committed to prosecuting this action and has retained competent
counsel experienced in litigation of this nature. Plaintiff&#146;s claims are typical of the claims of
the other members of the Class and Plaintiff has the same interests as the other members of the
Class. Plaintiff is an adequate representative of the Class and will fairly and adequately protect
the interests of the Class.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30.&nbsp;The prosecution of separate actions by individual members of the Class would
create the risk of inconsistent or varying adjudications with respect to individual members of the
Class, which would establish incompatible standards of conduct for defendants, or adjudications
with respect to individual members of the Class that would, as a practical matter, be dispositive
of the interests of the other members not parties to the adjudications or substantially members or
impede their ability to protect their interests.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31.&nbsp;To the extent defendants take further steps to effectuate the Proposed
Transaction, preliminary and final injunctive relief on behalf of the Class as a whole will be
entirely appropriate because defendants have acted, or refused to act, on grounds generally
applicable to the Class.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32.&nbsp;There are questions of law and fact that are common to the Class including,
<I>inter alia, </I>the following:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;whether the Individual Defendants have breached their fiduciary duties of due care, good
faith, and loyalty with respect to Plaintiff and the other members of the Class in connection with
the conduct alleged herein;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;whether the process implemented and set forth by the Individual Defendants in connection
with the Proposed Transaction was fair to the members of the Class;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;whether the Individual Defendants have breached their fiduciary duty of candor by failing
to disclose all material facts relating to the Proposed Transaction;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;whether CAI and Cerberus has aided and abetted the Individual Defendants&#146; breaches of
fiduciary duties owed to Plaintiff and the other members of the Class as a result of the conduct
alleged herein; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;whether Plaintiff and the other members of the Class would be irreparably harmed if
defendants are not enjoined from effectuating the Proposed Transaction described herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33.&nbsp;Plaintiffs claims are typical of the claims of the other members of the Class
and Plaintiff does not have any interests adverse to the Class.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34.&nbsp;Plaintiff anticipates that there will be no difficulty in the management of
this litigation. A class action is superior to other available methods for the fair and efficient
adjudication of this controversy.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>SUBSTANTIVE ALLEGATIONS</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35.&nbsp;BlueLinx, through its subsidiary, BlueLinx Corporation, distributes
approximately 10,000 products to 11,500 customers through its network of 70 warehouses and
third-party operated warehouses. It distributes products in two principal categories, structural
products and specialty products. Structural products include plywood, oriented strand board, rebar
and remesh, lumber, and other wood products primarily used for structural support, walls, and
flooring in construction projects. Its specialty products comprise roofing, insulation, specialty
panels, moulding, engineered wood products, vinyl products (used primarily in siding), composite
decking, and metal products (excluding rebar and remesh). The Company&#146;s customers include building
materials dealers, industrial users of building products, manufactured housing builders, and home
improvement centers. It sells its products through three distribution channels consisting of
warehouse sales, reload sales, and direct sales.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36.&nbsp;The Company started as a distribution division of the Georgia-Pacific Company.
On May&nbsp;7, 2004, Georgia-Pacific Company sold off assets to ABP
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Distribution Holdings, a new company owned by Cerberus, which was then merged into BlueLinx.
On December&nbsp;17, 2004, the Company consummated an initial public offering (&#147;IPO&#148;) at a price of $13.50 per share. Cerberus and it affiliates did
not sell any of their shares in the IPO. CAI currently owns 18.1&nbsp;million shares of BlueLinx stock,
or approximately 55.39% of the outstanding shares of the Company, an interest that it has
maintained since the IPO.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37.&nbsp;BlueLinx stock traded as high as $7.54 just over two years ago, but was
negatively affected by the global recession which hit the housing market especially hard. The
Company, however, is poised for growth. As noted by the Company in press release announcing 2010
first quarter results:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company incurred a net loss of $14.7&nbsp;million, or $0.48 per diluted share for the first
quarter of 2010, compared with a net loss of $60.7&nbsp;million, or $1.95 per diluted share, for
the first quarter of 2009. Revenues increased 6% to $431.1&nbsp;million from $407.1&nbsp;million for
the same period a year ago. Overall unit volume rose 1.4% compared to the year-ago period.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Gross profit for the first quarter totaled $52.3&nbsp;million, up 18% from $44.3&nbsp;million in the
prior-year period. Gross margins increased to 12.1% from the 10.9% generated in the year
earlier period. The improvement in margins was due to the Company&#146;s continued focus on
margin improvement, wood-based product pricing and an increase in sales through the
warehouse channel. Total operating expenses decreased $2.4&nbsp;million, or 3.9% from the same
period a year ago, as the Company continued to aggressively manage its cost structure.
Reported operating loss for the quarter was $8.0&nbsp;million, compared with an operating loss
of $18.4&nbsp;million a year ago.</TD>
</TR>




</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>&#147;While we achieved our first year over year quarterly increase in revenue in four years, our results were hindered by
unusually severe weather conditions through-out the country,&#148; said BlueLinx President and
CEO George Judd. <B>&#147;However, since the later part of the first quarter, we have seen an
increase in demand for our products as the housing market appears to have begun its
recovery.&#148; </B>(emphasis added).</TD>
</TR>

</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;38. The positive trend for the Company continued. As the Company&#146;s
press release announcing 2010 second quarter earnings notes:</div>



<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Revenues increased 27.7% to $540.8&nbsp;million from $423.5&nbsp;million for the same period a year
ago. The increase reflects a 45.1% increase in structural product sales and a 14.4%
increase in specialty product sales. Overall unit volume rose 11.9% compared to the
year-ago period. The Company incurred a net loss of $3.4&nbsp;million, or $0.11 per diluted
share for the second quarter of 2010, compared with net profit of $0.6&nbsp;million, or $0.02
per diluted share, for the second quarter of 2009, which benefited from $19.4&nbsp;million in
pre-tax net gains from significant special items.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Gross profit for the second quarter totaled $64.1&nbsp;million, up 32.8% from $48.3&nbsp;million in
the prior-year period. Gross margins increased to 11.9% from the 11.4% generated in the
year earlier period. Total operating expenses increased $22.8&nbsp;million, or 60.4% from the
same period a year ago, which benefited from $20.5&nbsp;million in net gains from significant
special items. Reported operating income for the quarter was $3.6&nbsp;million, compared with
an operating profit of $10.6&nbsp;million a year ago.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>&#147;The second -quarter business climate was characterized by unprecedented volatility in the
structural wood-based products market and a sluggish recovery of demand for products
related to new home construction.&#148; said BlueLinx President and CEO George Judd.
&#147; <B>Despite this challenging environment, we performed well as we grew our unit volume by
11.9% and increased our gross profit by</B></TD>
</TR>




</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><B>32.8%. </B>We also remained focused on cost management reducing our selling, general and
administrative expenses to 10.6% of sales.&#148;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>For the six months ended July&nbsp;3, 2010, net loss totaled $18.1&nbsp;million, or $0.59 per diluted
share, on revenues of $971.8&nbsp;million, compared with a net loss of $60.0&nbsp;million, or $1.93
per diluted share, on revenues of $830.6&nbsp;million a year ago. The increase in revenue was
largely due to the 14% increase in housing construction activity relative to the prior
period, increases in structural wood-based selling prices and the Company&#146;s focus on
targeted growth initiatives. Gross profit for the six months ended July&nbsp;3, 2010 totaled
$116.4&nbsp;million and gross margin was 12.0%, compared with $92.6&nbsp;million and 11.1%,
respectively, a year earlier. Operating expenses increased to $120.8&nbsp;million from $100.4
million a year ago, which included $19.4&nbsp;million in net gains from significant special
items. (emphasis added).</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39.&nbsp;Seeking to capture BlueLinx&#146;s upside for itself, on July 21, 2010, defendant Mayer, himself a member of the Board,
wrote on behalf of CAI to declare its intention to launch a tender offer for the
outstanding BlueLinx shares that it did not own for $3.40 per share:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Gentlemen:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Cerberus ABP Investor LLC (&#147;CAI&#148;) is pleased to advise you that it intends to commence a
tender offer for all of the outstanding shares of common stock of BlueLinx Holdings Inc. (&#147;
BlueLinx&#148; or the
&#147;Company&#148;) not owned by CAI, at a purchase price of $3.40 per share in cash. This
represents a premium of approximately 35.5% over the closing price on July&nbsp;21, 2010, and a
16.8% premium over the volume-weighted average closing price for the last 30 trading days.
In our view, this price represents a fair price to BlueLinx&#146;s stockholders.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The tender offer will be conditioned upon, among other things, the tender of a majority of
shares not owned by CAI or by the directors or officers of the Company and, unless waived,
CAI owning at least 90%</TD>
</TR>




</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><B></B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>of the outstanding BlueLinx common stock as a result of the tender or otherwise. Any shares
not acquired in the tender offer are expected to be acquired in a subsequent merger
transaction at the same cash price per share. The tender offer is not subject to any
financing or due diligence condition.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>We believe that our offer to acquire the shares of BlueLinx not owned by CAI represents a
unique opportunity for BlueLinx&#146;s stockholders to realize the value of their shares at a
significant premium to BlueLinx&#146;s current and recent stock price. As the longtime majority
stockholder of BlueLinx, we wish to acknowledge your dedicated efforts as board members of
the Company and to express our appreciation for the significant contribution that the board
members of BlueLinx have made to the Company in the challenging business and economic
environment of the past few years.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>In considering our tender offer, you should be aware that in our capacity as a stockholder
we are interested only in acquiring the BlueLinx shares not already owned by us and that in
our capacity as a stockholder we have no current interest in selling our stake in BlueLinx
nor would we currently expect, in our capacity as a stockholder, to vote in favor of any
alternative sale, merger or similar transaction involving BlueLinx other than the
transaction outlined here.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>CAI has not had any substantive discussions or negotiations with members of the Company&#146;s
management regarding their ability to &#147;roll&#148; their BlueLinx shares or stock options, or regarding any changes to existing employment agreements, equity
incentive plans or benefit arrangements, in connection with the tender offer. However, at the
appropriate time, we may explore, and discuss with management, any or all such topics.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>CAI does not expect the tender offer and merger to result in a change of control under the
Company&#146;s existing revolving credit facility or mortgage debt financing.</TD>
</TR>




</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>We intend to commence our tender offer within approximately seven days. CAI believes it
would be appropriate for the Company&#146;s board of directors to form a special committee
consisting of independent directors not affiliated with CAI to consider CAI&#146;s tender offer
and to make a recommendation to the Company&#146;s stockholders with respect thereto. In
addition, CAI encourages the special committee to retain its own legal and financial
advisors to assist in its review of our tender offer and the development of its
recommendation.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>We will file a Schedule&nbsp;13D amendment, and as such, we feel compelled to issue a press
release, a copy of which is attached for your information. We expect to make the release
public prior to the opening of the New York Stock Exchange on July&nbsp;22, 2010.</TD>
</TR>

</TABLE>
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
<BR>
CERBERUS ABP INVESTOR LLC<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Steven F. Mayer
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Steven F. Mayer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Managing Director&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40.&nbsp;Prior to the opening of the markets on July&nbsp;22, 2010, CAI issued a press release
announcing its intention to commence the Tender Offer and filed an amendment to its Schedule&nbsp;13D
with the Securities and Exchange Commission (&#147;SEC&#148;) which included a copy of its July&nbsp;21, 2010
letter to the Board.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;41.&nbsp;Also on July&nbsp;22, 2010, the Board formed a Special Committee of
defendants Marchese, Schumacher, and Grant. According to the Amended
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;14D-9 Recommendation Statement (&#147;Amended Recommendation Statement&#148;) filed with the SEC on September 27, 2010, the Special Committee was granted the
power and authority to:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>(i) review and evaluate the terms and conditions of the Offer; (ii)&nbsp;determine, together
with its advisors, whether the Offer is fair to, and in the best interests of, the Company
and its stockholders; (iii)&nbsp;recommend to the full Board what recommendation, if any, should
be made to the stockholders of the Company with respect to the Offer; (iv)&nbsp;participate in
negotiations with CAI with respect to the terms and conditions of the Offer; (v)&nbsp;if the
Special Committee deems appropriate, determine to reject the Offer; and (vi)&nbsp;take any
lawful action in response to the Offer that the Special Committee determines to be in the
best interests of the Company and its stockholders.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;42.&nbsp;The Special Committee retained the law firm of Jones Day as its legal counsel on
July&nbsp;22, 2010, retained Morris, Nichold, Arsht &#038; Tunnell LLP as special Delaware Counsel on July
25, 2010, and retained Citadel Securities LLC
(&#147;Citadel&#148;) as its financial advisor on July&nbsp;27, 2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;43.&nbsp;On August&nbsp;2, 2010, CAI commenced the Tender Offer at an offer price of $3.40 per
share and filed a Schedule&nbsp;TO and Schedule&nbsp;13E-3 with the SEC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44.&nbsp;On August&nbsp;13, the Company filed a Schedule&nbsp;14D-9 Recommendation Statement
(&#147;Initial Recommendation Statement&#148;) with the SEC, in which the Company took no current position regarding
the Tender Offer, noting that the Special Committee had not yet completed its review.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45.&nbsp;Between August&nbsp;2, 2010 and August&nbsp;20, 2010, Citadel, on behalf of the Special
Committee, and defendant Mayer, on behalf of CAI negotiated the terms of the Proposed Transaction,
including its price. On August&nbsp;20, 2010 Citadel, at the direction of the Special Committee,
indicated to defendant Mayer that it would recommend the Tender Offer if the consideration were
increased to $4.00 per share and if certain additional protections were offered to shareholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;46.&nbsp;On September&nbsp;3, 2010, defendant Schumacher agreed to recuse himself from further
meetings of the Special Committee in light of allegations that Schumacher&#146;s independence, and thus that of
the Special Committee, was called in question due to his service on the board of
directors of other companies affiliated with Cerberus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47.&nbsp;On September&nbsp;22, 2010, representatives for the Special Committee and CAI reached
agreement regarding the shareholder protections requested by the Special Committee, and CAI
announced that it was increasing the Tender Offer price to $4.00 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48.&nbsp;On September&nbsp;23, 2010, in consultation with Jones Day and Citadel, the Special
Committee unanimously voted on behalf of the Board and the Company to recommend that BlueLinx
shareholders accept the Tender Offer. On
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">September&nbsp;27, 2010 the Amended Recommendation Statement was filed with the SEC, disclosing the
Special Committee&#146;s recommendation.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49.&nbsp;The $4.00 per share agreed to in the Proposed Transaction is a
woefully inadequate price and appears designed to cap the market price of
BlueLinx common stock at current, depressed levels. Defendants&#146; rationale for asserting that the premium supports a fair price is unsound as
BlueLinx is just emerging from the bottom of a cycle that is expected to improve as the economy
continues to emerge from the recession. The &#147;premium&#148; touted by defendants is at a deep discount to the Comapny&#146;s 52-week high of $6.32. A fair
price cannot be based on a purported &#147;premium&#148; over a depressed market price and thus, the $4.00 price is unfair to shareholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50.&nbsp;The financial unfairness of the Proposed Transaction price is compounded by the
woefully deficient process undertaken by the Individual Defendants in agreeing to Proposed
Transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51.&nbsp;Given CAI and Ceberus&#146; control of the Board and of a majority of the outstanding shares of the Company, the
consummation of the Proposed Transaction is a <I>fait accompli. </I>While the Amended Recommendation
Statement notes that Citadel did solicit three potential acquirers of the Company, CAI and
Cerberus made clear in the July&nbsp;21, 2010 letter to the Board that CAI had &#147;no
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">current interest in selling our stake in BlueLinx nor would we currently expect, in our capacity as
a stockholder, to vote in favor of any alternative sale, merger or similar transaction involving
BlueLinx other than the transaction outlined here.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52.&nbsp;Further ensuring that the transaction is locked up in favor of CAI and Cerberus
is the fact that these entities control the Company and thus have complete inside knowledge of the
value of BlueLinx, information not available to any potential acquirers.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>The Materially Misleading And/or</B><BR>
<U><B>Incomplete Amended Recommendation Statement </B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;53.&nbsp;On September&nbsp;27, 2010, BlueLinx filed its Amended
Recommendation Statement regarding the Tender Offer with the SEC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;54.&nbsp;The Amended Recommendation Statement fails to provide the
Company&#146;s shareholders with material information and/or provides them with materially misleading information thereby rendering the
shareholders unable to make an informed decision regarding the tender of their shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;55.&nbsp;For example, the Amended Recommendation Statement fails to disclose certain
underlying methodologies, projections, key inputs and multiples relied upon and observed by Citidel
who served as financial advisor to the Company, which are necessary for shareholders to evaluate
and properly assess the credibility of the various analyses performed by Citadel and relied upon by
the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Board in recommending the Proposed Transaction. In particular, the Amended Recommendation
Statement is deficient and should provide, <I>inter alia</I>, the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;A description of the criteria and multiples observed by Citadel for each company in its
<I>Comparable Companies Analysis. </I>Further, a description for selecting a narrow reference range of
multiples ranging from 5.0x to 10.0x Enterprise Value/Adjusted EBITDA in the analysis.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;A description of the multiples observed by Citadel for each company in its <I>Precedent
Transaction Analysis. </I>Further, a description for selecting a narrow reference range of multiples
ranging from 5.0x to 8.0x Enterprise Value/Adjusted EBITDA in the analysis.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;A description of the criteria, companies and premia observed by Citadel for each company
in its <I>Premia Paid Analysis. </I>Further, a description for selecting a narrow reference range of
premia ranging from 35% to 50% used in the analysis.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;A description of whether the <I>Discounted Cash Flow Analysis</I>
included consideration of stock-based compensation.
</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;The free cash flow numbers used by Citadel in the computation of the <I>Discounted Cash Flow
Analysis </I>or the capital expenditure numbers and changes in working capital utilized by Citadel in
the same analysis.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;A description of the criteria to select a discount rate of 8% to 10% used by
Citadel in its <I>Discounted Cash Flow Analysis.</I>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56.&nbsp;The Amended Recommendation Statement also fails to disclose the complete
&#147;Stretch Plan&#148; for 2010 which was provided to CAI.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;57.&nbsp;The Amended Recommendation Statement also fails to disclose material information
regarding the sales process leading up to the Proposed Transaction including information regarding
the third party who executed a confidentiality and standstill agreement but indicated that it was
not interested in pursuing discussion before receiving any confidential materials.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58.&nbsp;The Amended Recommendation Statement fails to disclose what services, if any,
Citadel provided to the Company, CAI, or Cerberus in the past two years as well as the fees
received for such services and also fails to disclose what fee Cerberus will received in connection
with its engagement by the Special Committee. Information regarding the fees earned by Citadel is
material because any financial or economic interest in the Proposed Transaction could be perceived
as a conflict of interest.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59.&nbsp;Accordingly, Plaintiff seeks injunctive and other equitable relief to prevent
the irreparable injury that Company shareholders will continue to suffer absent judicial
intervention.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>COUNT I </B></U>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>On Behalf of Plaintiff for Violations of Section&nbsp;14(d)(4) and 14(e) of</B><BR>
<U><B>the Exchange Act Against BlueLinx and the Individual Defendants</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60. Plaintiff incorporates each and every allegation set forth above as if fully
set forth herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;61.&nbsp;BlueLinx and the Individual Defendants have issued the Amended Recommendation
Statement with the intention of soliciting shareholder support of the Proposed Transaction
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;62. Sections&nbsp;14(d)(4) and 14(e) of the Exchange Act require full and complete disclosure in
connection with tender offers. Specifically, Section 14(e) provides that:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>It shall be unlawful for any person to make any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements made, in the light of
the circumstances under which they are made, not misleading, or to engage in any
fraudulent, deceptive, or manipulative acts or practices, in connection with any tender
offer or request or invitation for tenders, or any solicitation of security holders in
opposition to or in favor of any such offer, request, or invitation. The Commission shall,
for the purposes of this subsection, by rules and regulations define, and prescribe means
reasonably designed to prevent, such acts and practices as are fraudulent, deceptive, or
manipulative.</TD>
</TR>




</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;63.&nbsp;Specifically, the Amended Recommendation Statement violates 14(d)(4) and 14(e)
because it omits material facts, including those set forth above. Moreover, in the exercise of
reasonable care, BlueLinx and the Individual Defendants should have known that the Amended
Recommendation Statement is materially misleading and omit material facts that are necessary to
render them non-misleading.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;64.&nbsp;The misrepresentations and omissions in the Amended Recommendation Statement are
material to Plaintiff, who will be deprived of his entitlement to be fully informed regarding the
tender of his shares prior to the expiration of the Tender Offer on October&nbsp;8, 2010.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>COUNT II </B></U>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>On Behalf of Plaintiff and the Class for Breach of</B><BR>
<U><B>Fiduciary Duties Against the Individual Defendants </B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;65.&nbsp;Plaintiff repeats and realleges each and every allegation set forth
herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66.&nbsp;The Individual Defendants have violated their fiduciary duties owed to the
shareholders of BlueLinx and have acted to put their personal interests ahead of the interests of
BlueLinx shareholders or acquiesced in those actions by fellow defendants. These Individual
Defendants have failed to take adequate measures to
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ensure that the interests of BlueLinx&#146;s shareholders are properly protected and have embarked on a process that provides CAI and Cerberus with an
unfair advantage by effectively excluding other alternative proposals.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67.&nbsp;By the acts, transactions, and courses of conduct alleged herein, the Individual
Defendants, individually and acting as a part of a common plan, will unfairly deprive Plaintiff and
other members of the Class of the true value of their BlueLinx investment. Plaintiff and other
members of the Class will suffer irreparable harm unless the actions of the Individual Defendants
are enjoined and a fair process is substituted.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;68.&nbsp;The Individual Defendants have breached their duties of loyalty, entire
fairness, good faith, and care by not taking adequate measures to ensure that the interests of
BlueLinx&#146;s public shareholders are properly protected from over-reaching by CAI and Cerberus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;69.&nbsp;By reason of the foregoing acts, practices, and courses of conduct, the
Individual Defendants have failed to exercise due care and diligence in the exercise of their
fiduciary obligations toward Plaintiff and the other members of the Class.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;70.&nbsp;As a result of the actions of Defendants, Plaintiff and the Class have been,
and will be, irreparably harmed in that they have not, and will not, receive
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">their fair portion of the value of BlueLinx&#146;s stock and businesses, and will be prevented from obtaining a fair price for their common stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;71.&nbsp;Unless enjoined by this Court, the Individual Defendants will continue to breach
the fiduciary duties owed to Plaintiff and the Class and may consummate the Proposed Transaction to
the disadvantage of the shareholders, without providing sufficient information to enable BlueLinx&#146;s shareholders to make an informed
decision regarding the Tender Offer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;72.&nbsp;The Individual Defendants have engaged in self-dealing, have not acted in good
faith, and have breached, and are breaching, fiduciary duties owed to Plaintiff and the other
members of the Class.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;73.&nbsp;Plaintiff and the Class have no adequate remedy at law. Only through the
exercise of this Court&#146;s equitable powers can Plaintiff and the Class be fully protected from the immediate and irreparable injury which these
actions threaten to inflict.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>COUNT III </B></U>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>On Behalf of Plaintiff and the Class for Aiding and Abetting the</B><BR>
<U><B>Individual Defendants&#146; Breaches of Fiduciary Duties Against CAI and<BR>
Cerberus</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;74.&nbsp;Plaintiff repeats and realleges each and every allegation set forth
herein.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;75.&nbsp;The Individual Defendants breached their fiduciary duties to the
BlueLinx shareholders by the actions alleged <I>supra</I>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;76.&nbsp;Such breaches of fiduciary duties could not, and would not, have occurred but
for the conduct of defendants CAI and Cerberus which, therefore, aided and abetted the Individual Defendants&#146; breaches.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;77.&nbsp;Defendants CAI and Cerberus had knowledge that they were aiding and abetting the
Individual Defendants&#146; breaches of fiduciary duties to BlueLinx shareholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;78.&nbsp;Defendants CAI and Cerberus rendered substantial assistance to the Individual
Defendants in their breaches of their fiduciary duties to BlueLinx shareholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;79.&nbsp;As a result of the unlawful actions of CAI and Cerberus, Plaintiff and the other
members of the Class will be irreparably harmed in that they will be prevented from obtaining the
fair value of their equity ownership in the Company. Unless enjoined by the Court, CAI and Cerberus
will continue to aid and abet the Individual Defendants&#146; breaches of their fiduciary duties owed to Plaintiff and the members
of the Class, and will aid and abet a process that inhibits the maximization of shareholder value
and the disclosure of material information.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;80.&nbsp;Plaintiff and the other members of the Class have no adequate remedy at law.
Only through the exercise of this Court&#146;s equitable powers can Plaintiff and the Class be fully protected from immediate and irreparable
injury which
Defendants&#146; actions threaten to inflict.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>PRAYER FOR RELIEF</B></U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREFORE, Plaintiff demands judgment and preliminary and permanent relief, including
injunctive relief, in her favor and in favor of the Class, and against the defendants as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.&nbsp;Certifying this case as a class action, certifying Plaintiff as class
representative and their counsel as class counsel;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.&nbsp;Declaring that the conduct of the Individual Defendants in approving the Proposed
Transaction and failing to negotiate in good faith with CAI and Cerberus and other acts and
omissions set forth herein are breaches of the Individual Defendants&#146; fiduciary duties;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C.&nbsp;Preliminarily and permanently enjoining the Individual Defendants and all persons
acting in concert with them from taking any steps to consummate the Proposed Transaction on the
disclosures and terms presently proposed;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D.&nbsp;Preliminarily and permanently enjoining the Individual Defendants
from initiating any defensive measures that would inhibit the Individual
Defendants&#146; ability to maximize value for
BlueLinx shareholders;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E.&nbsp;To the extent the Proposed Transaction is consummated prior to this Court&#146;s entry of a final judgment, rescinding it and setting it aside or awarding rescissory damages;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;F.&nbsp;Directing Defendants to account to Plaintiff and the Class for all damages
suffered by them as a result of defendants&#146; wrongful conduct alleged herein;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;G.&nbsp;Awarding Plaintiff the costs, expenses, and disbursements of this action,
including attorneys&#146; and experts&#146; fees and, if applicable, pre-judgment and post-judgment interest; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;H.&nbsp;Awarding Plaintiff and the Class such other relief as this Court deems just,
equitable, and proper.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">Dated: September 30, 2010                               &nbsp;</TD>
    <TD colspan="3" align="left"><B>HOLZER HOLZER &#038; FISTEL LLC</B><BR>

<BR>
<B>HOLZER HOLZER &#038; FISTEL, LLC</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ Marshall P. Dees
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Corey D. Holzer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Georgia Bar Number: 364698<BR>
Michael I. Fistel, Jr.<BR>
Georgia Bar Number: 262062<BR>
Marshall P. Dees<BR>
Georgia Bar Number: 105776<BR>
William W. Stone<BR>
Georgia Bar Number: 273907<BR>
200 Ashford Center North<BR>
Suite 300<BR>
Atlanta, Georgia 30338<BR>
Telephone: 770-392-0090<BR>Facsimile: 770-392-0029&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">OF COUNSEL:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>FARUQI &#038; FARUQI, LLP</B><BR>
David H. Leventhal<BR>
369 Lexington Ave., 10th Floor<BR>
New York, NY 10017<BR>
Tel: 212-983-9330<BR>
Fax: 212-983-9331

</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
